As China Doubles Down on COVID Zero, Deal Lawyers Stay Cautiously Optimistic
BY Sarah Wong |
Stringent pandemic curbs, domestic economic headwinds, and tightening regulatory controls have put a dampener on mergers and acquisitions activity in China so far this year. And the leader of the world’s second-largest economy has hardly reassured market observers hoping for a robust revival for the remainder of 2022.